The contents are under continuing development and improvements and may contain errors of omission or fact. This is not to be used for the assessment, diagnosis or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website.


Acute Disseminated Encephalomyelitis

Learning objectives

  • Relevant as a stroke mimic
  • What is ADEM syndrome
  • Recognition of ADEM syndrome
  • Treatment of ADEM syndrome


  • Relevant as a stroke mimic and so should be identifiable
  • Acute disseminated encephalomyelitis mainly affects children but can affect adults
  • Inflammatory condition of brain and spinal cord that damages myelin
  • May follow a viral illness or have another precipitant
Many patients initially diagnosed with ADEM develop clinically definite MS upon long-term follow-up.


  • Classically acute and monophasic but not always
  • Usually affects young adults and children
  • Pathological hallmark of ADEM is perivenular inflammation with limited "sleeves of demyelination"
  • CSF elevated IFN-gamma, IL-6, and IL-8


  • Bacterial infections: mycoplasma, Gram negative organisms, salmonella typhi
  • Vaccination for measles, mumps, or rubella.
  • Post viral:Measles, varicella, rubella, Herpes-zoster, Infectious mononucleosis
  • Cerebral malaria


  • Fever, meningism, seizures, coma, usually monophasic but not always
  • Weakness, hemianopia, neglect


  • CT: may show cerebral oedema
  • MRI scan:large symmetrical lesions with basal ganglia and thalamus involved.
  • LP: raised protein and slight increase in WCC in 80%.Protein > 100mg/dl. No oligoclonal bands
  • Brain biopsy: consistent with demyelination.


  • Multiple sclerosis
  • Susac syndrome
  • Progressive multifocal leukoencephalopathy


  • Mortality is up to 30%
  • Treat with high dose IV Methylprednisolone
  • Alternatives include Plasmapharesis, IVIG and Rituximab

References and further reading

Note: The plan is to keep the website free through donations and advertisers that do not present any conflicts of interest. I am keen to advertise courses and conferences. If you have found the site useful or have any constructive comments please write to me at drokane (at) I keep a list of patrons to whom I am indebted who have contributed. If you would like to advertise a course or conference then please contact me directly for costs and to discuss a sponsored link from this site.

free web counter Hits